Arash Kardan, M.D.
Picture
Arash Kardan, M.D.
Associate Professor
Positions
- Associate Professor
-
Radiology
Baylor College of Medicine
Houston, Texas
- Section Chief of Nuclear Medicine and Molecular Imaging
-
Radiology
Baylor College of Medicine
Houston, Texas
- Chair of the Radiation Safety Committee
-
Radiation Safety Program
Baylor St. Luke's Medical Center
Houston, Texas
- Chief of Nuclear Medicine
-
Radiology
Ben Taub General Hospital-Harris Health System
Houston, Texas
- Chief of PET/CT
-
Radiology
Smith Clinic-Harris Health System
Houston, Texas
Addresses
- Baylor College of Medicine (Office)
-
Department of Radiology
One Baylor Plaza
Houston, TX 77030
United States
Phone: (713) 798-4417
arash.kardan@bcm.edu
Education
- MD from Universidad Autonoma de Guadalajara
- 06/1999 - Guadalajara, Jalisco Mexico
- Postdoctoral Training at New York Medical College
- 06/2000 - Valhalla, New York United States
- 5th Pathway Program
- Residency at Tucson Hospitals Medical Education Program/University of Arizona
- 06/2003 - Tucson, Arizona United States
- Internal Medicine Residency
- Fellowship at Massachusetts General Hospital/Harvard Medical School
- 06/2006 - Boston, Massachusetts United States
- Cardiovascular Disease Fellowship/Nuclear Cardiology and Cardiac PET Fellowship
- Fellowship at Massachusetts General Hospital/Harvard Medical School
- 06/2008 - Boston, Massachusetts United States
- NIH T32 Advanced Molecular Imaging and Novel Radiotracer Development Fellowship
- Fellowship at Stanford University
- 06/2010 - Palo Alto, California United States
- Nuclear Medicine Fellowship/Molecular Imaging Program at Stanford
- Fellowship at Stanford University
- 06/2011 - Palo Alto, California United States
- Oncology PET/CT Fellowship/Stanford Cancer Center/Molecular Imaging Program at Stanford
Honors & Awards
- NIH T32 Ruth L. Kirschstein National Research Service Award (NRSA)
- Advanced Molecular Imaging and Novel Radiotracer Development
- National Institutes of Health (07/2006 - 06/2008)
- Patients' Choice Award (2018, 2017, 2015, 2014, 2011)
- Vitals.com
- Compassionate Doctor Recognition (2018, 2017, 2015, 2014, 2011)
- Vitals.com
- On-Time Doctor Award (2018, 2017, 2015, 2014)
- Vitals.com
Professional Interests
- Diagnostic and Therapeutic Nuclear Medicine
- Molecular Imaging
- PET/CT
- PET/MRI
- Nuclear Cardiology and Cardiac PET
- Theranostics
- Neuroendocrine Tumors/PRRT
- Novel Radiotracer and Therapeutics Development
- Medical Education
Websites
Selected Publications
- Mohamed, A., Asa, S., Lee, Z., Tirumani, S., Li, Q., Avril, N., Bajor, D., Mahipal, A., Chakrabarti, S., Selfridge, J., Kardan, A. "The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experience." J. Gastrointest. Oncol.. 2023 Apr;14(2) Pubmed PMID: 37201086
- "Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology." 2021 Jul 28;19(7):839-868. Pubmed PMID: 34340212
- "ACGME Nuclear Radiology Milestones 2.0." 2021 Apr;
- CR Dodson, C Marshall, JC Durieux, PF Wojtylak, JC Davidson, RF Muzic, and A Kardan "Using an Assumed Lung Mass Inaccurately Estimates the Lung Absorbed Dose in Patients Undergoing Hepatic 90 Yttrium Radioembolization Therapy." Cardiovasc Intervent Radiol. 2022 Aug 4; Pubmed PMID: 35925379
- Arash Kardan, Serah Choi, Martin Satter, Andrew Sloan, Raymond F. Muzic "Chapter 35 - Methionine PET – overview and application to brain tumour imaging and treatment." Handbook of Neuro-Oncology Neuroimaging (Third Edition), Editor(s): Herbert B. Newton. 2022;439-459.
- Graf J, Jacobs M, Gladd-Foley D, Ruiz-Irizarry Y, Kivitz A, Churchill M, Kardan A, Leach M, Ralph D, Korczak N, Hasselbach A, Abbruzzese B, Hershey R, Potter B, Fitzpatrick J, Thornton A, Blue M, Rosol M. "Tc99m Tilmanocept Imaging Predicts Clinical Response in Rheumatoid Arthritis Patients Beginning New Anti-TNFα Therapy." Arthritis Rheumatol.. 2022 Nov;74(Supplement 9)
- A Kulkarni, L Zimmerman, P Wojtlylak, S Deng, R Al Helo, NA Harris, D Jordan, and A Kardan "Performance Evaluation of a GE Discovery NM/CT 870 DR and a GE Discovery 670 CZT for Radium-223 Digital SPECT/CT Imaging." AAPM 2022. 2022 Jul;
- Muzic et al. "Abdominopelvic MR to CT registration using a synthetic CT intermediate." J Appl Clin Med Phys. 2022 Aug 3; Pubmed PMID: 35920116
- Mohamed A, Asa SL, McCormick T, Al-Shakhshir H, Dasari A, Mauricio R, Salem I, Ocuin LM, Bajor D, Lee RT, Selfridge JE, Kardan A, Lee Z, Avril N, Kopp S, Winter JM, Hardacre JM, Ammori JB, Ghannoum MA. "The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs)." Curr Issues Mol Biol. 2022 Apr 30;44(5):2015-2028. Pubmed PMID: 35678665
- Arsenault T, Labak CM, Chaung K, Muzic RF Jr, Kardan A, Sloan A, Choi S, Podder T, Ouyang Z "Treating Recurrent Brain Metastases Using GammaTile Brachytherapy: A Case Report and Dosimetric Modeling Method." Cureus. 2021 Nov;13(11) Pubmed PMID: 34877209
- Patrick Wojtylak, Robert Jones, Lina Mehta, Norbert Avril and Arash Kardan "Implementation of a Lung Perfusion Only ImagingProtocol with SPECT or SPECT/CT in a Major AcademicUniversity Hospital Healthcare System in Adaption to theCOVID-19 Pandemic." J Nucl Med. 2021 May;62(Suppl 1):180.
- Patrick Wojtylak and Arash Kardan "Utilization of Gallium-68 Dotatate PET MRI for the Evaluation of Meningioma in a Major Tertiary Academic University Neurosurgical Center." J Nucl Med. 2021 May;62(Suppl 1):3000.
- Patrick Wojtylak, Norbert Avril and Arash Kardan "Feasibility and initial experience in the utilization of a fully digital CZT SPECT/CT system for the diagnosis of transthyretin cardiac amyloidosis (ATTR)." J Nucl Med. 2020 May;61(Suppl 1):3040.
- Leonard Zimmermann, Patrick Wojtylak and Arash Kardan "Improved Sentinel Node Localization in Patients with Newly Diagnosed Melanoma Utilizing a Fully Digital CZT SPECT/CT System Versus a Conventional NaI SPECT/CT System." J Nucl Med. 2020 May;61(Suppl 1):328.
- Devita R, Chagarlamudi K, Kardan A "Synchronous osseous metastasis, degenerative changes, and incidental multifocal Paget's disease in a case of newly diagnosed prostatic carcinoma." World J Nucl Med. 2020 Jan;19(2):144-46. Pubmed PMID: 32939203
- T Richards, J Anderson, M Reed, R Poelstra, M Satter, and A Kardan "Chapter 14 - Advanced [11C]methionine and [18F]FDG positron emission tomography for diagnosis, treatment, and follow-up of oligodendrogliomas." Oligodendroglioma: Clinical Presentation, Pathology, Molecular Biology, Imaging, and Treatment. 2019;157-71.
- Arash Kardan, Bonnie Abbruzzese, Allison Kissling, Matthew Haynam, David Ralph, Rachael Hershey, Ahmad Ismail, Michael Blue, Carley Hartings, Izabela Gierach, Hannah Bailey, Christopher Gabelmann, George Zubal, Maria Corsi and Frederick Cope "Intravenous 99mTc-tilmanocept in Planar and Fused SPECT/CT Imaging of Activated Macrophage Infiltration in Subjects with Active Rheumatoid Arthritis." J Nucl Med. 2018 May;59(Suppl 1):110.
- Arash Kardan, Allison Kissling, Carley Hartings, Rachael Hershey, Michael Blue, David Ralph, Michael Rosol, Ayah Hussein, Katherine Repp, Lori Christman, Maria Corsi, Ron Korn, Frederick Cope and Bonnie Abbruzzese "A Phase I/Phase II Study of Intravenously (IV) Administered Tc 99m Tilmanocept (TCT) to Determine Safety, Tolerability, Optimal Clinical Dose Selection, and Imaging Timepoint in Patients Clinically Diagnosed with Rheumatoid Arthritis (RA)." J Nucl Med. 2019 May;60(Suppl 1):89.
- Arash Kardan, Roxane Weighall, James Sayre and Melanie Weaver "Comparison of 99mTc-Tilmanocept and 99mTc-Sulfur Colloid for Intraoperative Lymphatic Mapping and Sentinel Lymph Node Biopsy in Breast Cancer Patients." J Nucl Med. 2018 May;59(Suppl 1):418.
- Arash Kardan, Martin Satter "Chapter 34 - Advanced Methionine Positron-Emission Tomography Imaging for Brain Tumor Diagnosis, Surgical Planning, and Treatment." Handbook of Neurooncology Neuroimaging 2nd Ed.. 2016;371-84.
- Kim ES, Satter M, Reed M, Fadell R, Kardan A. "A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma." Neuroradiol J. 2016 Jun;29(3):193-7. Pubmed PMID: 27122050
- Guy MS, Kardan A "(111)In WBC SPECT/CT detection of a radiographically occult solitary infected renal cyst in polycystic kidney disease." Clin Nucl Med. 2015 Jun;40(6):542-4. Pubmed PMID: 25783512
- Short RG, Bal S, German JP, Poelstra RJ, Kardan A "Potential of F-18 PET/CT in the Detection of Leptomeningeal Metastasis." Neuroradiol J. 2014 Dec;27(6):685-9. Pubmed PMID: 25489891
- Short RG, Kardan A "18F-FDG PET/CT in a 16-year-old patient with hydranencephaly." Clin Nucl Med. 2014 Oct;39(10):445-7. Pubmed PMID: 24395017
- Guy MS, Jacob C, McDonald SD, Dowdy YG, Kardan A "18F-FDG PET/CT metabolic variability in functioning oncocytic parathyroid adenoma with brown tumors." Clin Nucl Med. 2014 Apr;39(4):393-5. Pubmed PMID: 24561686
- "Myocardial Perfusion Imaging: From Diagnosis to Prognosis." Primary Care Reports. 2013 Jan 1;
- Mittra ES, Goris ML, Iagaru AH, Kardan A, Burton L, Berganos R, Chang E, Liu S, Shen B, Chin FT, Chen X, Gambhir SS "Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels." Radiology. 2011 Jul;260(1):182-91. Pubmed PMID: 21502381
- El Fakhri G, Kardan A, Sitek A, Dorbala S, Abi-Hatem N, Lahoud Y, Fischman A, Coughlan M, Yasuda T, Di Carli MF "Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET." J Nucl Med. 2009 Jul;50(7):1062-71. Pubmed PMID: 19525467
- David Elmaleh, Arash Kardan, Sandra Barrow, Steven Dragotakes, John Correia, Steven Weise, Boyan Goumnerov, Ljiljana Kundakovic, Henry Gewirtz and Alan Fischman "A phase I study evaluating dosimetry and myocardial pharmacokinetic behavior of BFPET, a new F-18 labeled tracer for myocardial perfusion imaging." J Nucl Med. 2009 May;50(Suppl 2):420.
- Arash Kardan, Timothy Shoup, Sandra Barrow, Steven Dragotakes, David Elmaleh and Alan Fischman "A phase I study evaluating myocardial pharmacokinetic behavior of CardioPET, a new cardiac PET tracer, in normal subjects and subjects with stable coronary artery disease." J Nucl Med. 2008 May;49(Suppl 1):192.
- Gregory SA, MacRae CA, Aziz K, Sims KB, Schmahmann JD, Kardan A, Morss AM, Ellinor PT, Tawakol A, Fischman AJ, Gewirtz H "Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathy." Coron Artery Dis. 2007 Feb;18(1):15-22. Pubmed PMID: 17172925
Memberships
- SNMMI
- Southwest Chapter Board of Trustees
- NIH/NCI Center for Cancer Research Office of Sponsor and Regulatory Oversight
- Imaging/Radiation Therapy Committee Data and Safety Monitoring Board (07/2023)
- ACGME Nuclear Radiology Milestones Working Group
- (01/2019 - 07/2021)
- NCCN Neuroendocrine and Adrenal Tumors Guidelines Panel
- (01/2019 - 06/2022)
- Neuroendocrine Tumor Research Foundation
Languages
Spanish, Farsi
Log In to edit your profile
